# OnCo record paper-eln-2022-aml-dohner-blood-2022 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-eln-2022-aml-dohner-blood-2022/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-eln-2022-aml-dohner-blood-2022" ;
  schema:name "ELN 2022: diagnosis and management of acute myeloid leukaemia in adults"@en ;
  schema:description "The European LeukemiaNet 2022 recommendations define how acute myeloid leukaemia is classified by its genetics into favourable, intermediate and adverse risk, and how those groups should be treated and monitored."@en ;
  schema:url <https://onco.cc/key-papers/paper-eln-2022-aml-dohner-blood-2022/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1182/blood.2022016867>, <https://pubmed.ncbi.nlm.nih.gov/35797463/> ;
  schema:sameAs <https://doi.org/10.1182/blood.2022016867> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Döhner H, Wei AH, Appelbaum FR, et al." ;
  onco:cancers <https://onco.cc/cancers/aml-older-unfit/>, <https://onco.cc/cancers/aml-flt3/>, <https://onco.cc/cancers/aml-npm1-kmt2a/>, <https://onco.cc/cancers/aml-idh/>, <https://onco.cc/cancers/aml-secondary/> ;
  onco:journals <https://onco.cc/journals/blood/> .
